NCT05753007 2026-03-16A Clinical Trial of a Hemp-Derived, High Cannabidiol Product for Anxiety in Glioblastoma PatientsMclean HospitalPhase 2 Terminated2 enrolled 13 charts
NCT05388058 2026-01-16Topical Cannabidiol for the Treatment of Chemotherapy-Induced Peripheral NeuropathyMayo ClinicPhase 2 Completed40 enrolled 15 charts